Viewing Study NCT02779751


Ignite Creation Date: 2025-12-24 @ 11:57 PM
Ignite Modification Date: 2025-12-30 @ 11:11 PM
Study NCT ID: NCT02779751
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-04-18
First Post: 2016-05-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Abemaciclib (LY2835219) in Participants With Non-Small Cell Lung Cancer or Breast Cancer
Sponsor: Eli Lilly and Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module